Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Microbiol Spectr ; 11(6): e0095423, 2023 Dec 12.
Article in English | MEDLINE | ID: mdl-37815336

ABSTRACT

IMPORTANCE: The in vitro assessment of diruthenium(II)-arene compounds against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus showed a significant antibacterial activity of some compounds against S. pneumoniae, with minimum inhibitory concentration (MIC) values ranging from 1.3 to 2.6 µM, and a medium activity against E. coli, with MIC of 25 µM. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appear to significantly influence the antibacterial activity. Fluorescence microscopy showed that these ruthenium compounds enter the bacteria and do not accumulate in the cell wall of gram-positive bacteria. These diruthenium(II)-arene compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies, especially the compounds bearing larger benzo-fused lactam substituents.


Subject(s)
Ruthenium , Staphylococcal Infections , Humans , Staphylococcus aureus , Ruthenium/pharmacology , Escherichia coli , Anti-Bacterial Agents/pharmacology , Streptococcus pneumoniae , Microbial Sensitivity Tests
2.
Adv Mater ; 35(35): e2300308, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37086157

ABSTRACT

Conjugated polymers are increasingly used as organic mixed ionic-electronic conductors in electrochemical applications for neuromorphic computing, bioelectronics, and energy harvesting. The design of efficient electrochemical devices relies on large modulations of the polymer conductivity, fast doping/dedoping kinetics, and high ionic uptake. In this work, structure-property relations are established and control of these parameters by the co-existence of order and disorder in the phase morphology is demonstrated. Using in situ time-resolved spectroelectrochemistry, resonant Raman, and terahertz (THz) conductivity measurements, the electrochemical doping in the different morphological domains of poly(3-hexylthiophene) (P3HT) is investigated. The main finding is that bipolarons are found preferentially in disordered polymer regions, where they are formed faster and are thermodynamically more favored. On the other hand, polarons show a preference for ordered domains, leading to drastically different bipolaron/polaron ratios and doping/dedoping dynamics in the distinct regions. A significant enhancement of the electronic conductivity is evident when bipolarons start forming in the disordered regions, while the presence of bipolarons in the ordered regions is detrimental for transport. This study provides significant advances in the understanding of the impact of morphology on the electrochemical doping of conjugated polymers and the induced increase in conductivity.

3.
Molecules ; 28(2)2023 Jan 16.
Article in English | MEDLINE | ID: mdl-36677958

ABSTRACT

Eight novel carbohydrate-tethered trithiolato dinuclear ruthenium(II)-arene complexes were synthesized using CuAAC 'click' (Cu(I)-catalyzed azide-alkyne cycloaddition) reactions, and there in vitro activity against transgenic T. gondii tachyzoites constitutively expressing ß-galactosidase (T. gondii ß-gal) and in non-infected human foreskin fibroblasts, HFF, was determined at 0.1 and 1 µM. When evaluated at 1 µM, seven diruthenium-carbohydrate conjugates strongly impaired parasite proliferation by >90%, while HFF viability was retained at 50% or more, and they were further subjected to the half-maximal inhibitory concentration (IC50) measurement on T. gondii ß-gal. Results revealed that the biological activity of the hybrids was influenced both by the nature of the carbohydrate (glucose vs. galactose) appended on ruthenium complex and the type/length of the linker between the two units. 23 and 26, two galactose-based diruthenium conjugates, exhibited low IC50 values and reduced effect on HFF viability when applied at 2.5 µM (23: IC50 = 0.032 µM/HFF viability 92% and 26: IC50 = 0.153 µM/HFF viability 97%). Remarkably, compounds 23 and 26 performed significantly better than the corresponding carbohydrate non-modified diruthenium complexes, showing that this type of conjugates are a promising approach for obtaining new antiparasitic compounds with reduced toxicity.


Subject(s)
Ruthenium , Toxoplasma , Humans , Antiparasitic Agents/pharmacology , Ruthenium/pharmacology , Galactose/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...